Industry sees very little harmony in the way European countries respond to reports of adverse incidents
This article was originally published in Clinica
Executive Summary
Companies marketing medical devices in Europe face a bewildering variety of responses from regulatory authorities when they report adverse incidents or near adverse incidents with their products as required by law. Amanda Maxwell reports from a workshop in London which highlighted the differences.